Predictive Performance of NEWS-2 and NEWS-Calcium Scores for In-Hospital Mortality in Older Patients With Acute Pancreatitis (NEWS)

June 6, 2026 updated by: Antalya Health Sciences University

Comparison of the Predictive Performance of NEWS-2 and NEWS-Calcium Scores on In-Hospital Mortality in Patients Aged 65 Years and Older Diagnosed With Acute Pancreatitis in the Emergency Department.

Acute pancreatitis is an important gastrointestinal emergency that may lead to mortality, particularly in older patients. This retrospective, single-center observational prognostic validation study aims to compare the predictive performance of the National Early Warning Score 2 (NEWS-2) and NEWS-Calcium scores for in-hospital mortality in patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department.

Electronic medical records of eligible patients will be reviewed retrospectively. Demographic characteristics, vital signs, serum calcium levels, clinical outcomes, intensive care unit admission, organ failure, length of hospital stay, and in-hospital mortality will be recorded. NEWS-2 will be calculated using vital parameters at admission, while the NEWS-Calcium score will be obtained by adding a calcium-based score to NEWS-2.

The primary outcome will be in-hospital mortality. Secondary outcomes will include intensive care unit admission, severe acute pancreatitis, persistent organ failure, and length of hospital stay. The predictive performances of the scores will be compared using ROC curve analysis, AUC values, and the DeLong test. This study aims to identify the most appropriate early prognostic score for older patients with acute pancreatitis and to support clinical decision-making in emergency settings.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Acute pancreatitis is a common gastrointestinal emergency that may be associated with significant morbidity and mortality, particularly in older patients. In individuals aged 65 years and older, reduced physiological reserve, increased comorbidity burden, and delayed clinical deterioration may make early risk stratification more important in the emergency department.

The National Early Warning Score 2 (NEWS-2) is a widely used clinical scoring system based on routinely measured physiological parameters, including respiratory rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness, temperature, and supplemental oxygen use. Calcium abnormalities, especially hypocalcemia, may also be associated with disease severity and poor outcomes in acute pancreatitis. Therefore, a calcium-integrated scoring approach may improve early prognostic assessment in this patient population.

This study is designed as a single-center, retrospective, observational prognostic validation study. The study will include patients aged 65 years and older who were admitted to the emergency department and diagnosed with acute pancreatitis during the predefined study period. Eligible patients will be identified through electronic medical records. Demographic characteristics, comorbidities, vital signs at emergency department admission, laboratory parameters including serum calcium levels, clinical outcomes, intensive care unit admission, organ failure status, length of hospital stay, and in-hospital mortality will be recorded.

The NEWS-2 score will be calculated using physiological parameters measured at the time of emergency department admission. The NEWS-Calcium score will be calculated by adding a calcium-based component to the NEWS-2 score according to serum total or corrected calcium levels. The primary outcome of the study will be in-hospital mortality. Secondary outcomes will include intensive care unit admission, development of severe acute pancreatitis, persistent organ failure, and length of hospital stay.

The main objective of this study is to compare the predictive performance of NEWS-2 and NEWS-Calcium scores for in-hospital mortality in older patients with acute pancreatitis. Receiver operating characteristic (ROC) curve analysis will be used to evaluate the prognostic performance of each score. The area under the curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value, and optimal cut-off values will be calculated. The AUC values of NEWS-2 and NEWS-Calcium will be compared using the DeLong test.

This study is expected to provide evidence on whether the addition of serum calcium to NEWS-2 improves early mortality prediction in geriatric patients with acute pancreatitis. The findings may contribute to early risk stratification, clinical decision-making, and appropriate allocation of intensive care resources in the emergency department.

Study Type

Observational

Enrollment (Estimated)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
    • konyaaltı
      • Antalya, konyaaltı, Turkey (Türkiye), 07100
        • University of Health Sciences, Antalya Training and Research Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of patients aged 65 years and older who were admitted to the emergency department and diagnosed with acute pancreatitis during the predefined study period. Eligible patients will be identified retrospectively through electronic medical records. Patients with available admission vital signs, serum calcium levels, and in-hospital outcome data will be included. Patients with missing data required for calculation of NEWS-2 or NEWS-Calcium scores, unavailable outcome data, or transfer before outcome assessment will be excluded. Only the first eligible admission will be analyzed for patients with recurrent admissions.

Description

Inclusion Criteria:

  • Age 65 years or older.
  • Admission to the emergency department with a diagnosis of acute pancreatitis during the study period.
  • Diagnosis of acute pancreatitis established according to clinical presentation, serum pancreatic enzyme levels, and/or imaging findings.
  • Availability of admission vital parameters required to calculate the National Early Warning Score 2 (NEWS-2).
  • Availability of serum calcium measurement at emergency department admission.
  • Availability of in-hospital clinical outcome data.

Exclusion Criteria:

  • Age younger than 65 years.
  • Absence of a confirmed diagnosis of acute pancreatitis.
  • Missing data required to calculate NEWS-2 or NEWS-Calcium scores.
  • Missing serum calcium measurement at admission.
  • Incomplete medical records or unavailable in-hospital outcome data.
  • Transfer to another hospital before clinical outcome assessment.
  • Recurrent admissions during the study period; only the first eligible admission will be analyzed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients Aged 65 Years and Older with Acute Pancreatitis
This cohort will include patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department. Data will be collected retrospectively from electronic medical records. No intervention will be administered. NEWS-2 and NEWS-Calcium scores will be calculated using admission data, and their predictive performance for in-hospital mortality will be compared.
Other: Retrospective Calculation of NEWS-2 Score
he National Early Warning Score 2 (NEWS-2) will be calculated retrospectively using physiological parameters recorded at emergency department admission, including respiratory rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness, body temperature, and supplemental oxygen use. No intervention will be administered to patients as part of this study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In-Hospital Mortality
Time Frame: From emergency department admission to hospital discharge or in-hospital death, up to 30 days.
n-hospital mortality will be defined as death occurring during the index hospitalization among patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department. Mortality status will be obtained retrospectively from electronic medical records.
From emergency department admission to hospital discharge or in-hospital death, up to 30 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Antalya Health Sciences University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 15, 2026

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

October 15, 2026

Study Registration Dates

First Submitted

June 6, 2026

First Submitted That Met QC Criteria

June 6, 2026

First Posted (Actual)

June 11, 2026

Study Record Updates

Last Update Posted (Actual)

June 11, 2026

Last Update Submitted That Met QC Criteria

June 6, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9/23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. This is a retrospective study based on electronic medical records, and individual-level patient data will not be made available to other researchers due to confidentiality, ethical, and institutional data protection regulations. Only aggregated and anonymized study results will be reported.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis (AP)

Clinical Trials on Retrospective Calculation of NEWS-2 Score

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe